Freshfields and Wachtell steer AstraZeneca/Alexion

AstraZeneca has tapped Freshfields Bruckhaus Deringer to guide its $39 billion acquisition of Alexion Pharmaceuticals, which is being advised by Wachtell Lipton Rosen & Katz.


Get unlimited access to all Global Competition Review content